Ri.MED Foundation organizes every year a Scientific Symposium, centered on subjects in the 8 research fields of interest, in which Ri.MED researchers and keynote speakers show their scientific results. Each edition of the event raises attention from the scientific community and from the press.
The 3th edition of the annual scientific Ri.MED Symposium took “Infection and Mutation: The Two Major Threats to our Species, and How They Can be Managed at the Molecular Level” place on October 26, 20109 in Palermo, Fondazione Banco di Sicilia.
The 3th Ri.MED Symposium – as well as previous editions – reserves to the participants the opportunity to attend a preview presentation of important scientific results, not yet disclosed.
We thank all participants for their contribution to the success of this important occasion of exchange and scientific divulgation.
Program
9:00 am: Registration
9:15 am: Paolo Pucci di Benisichi, Bruno Gridelli Welcome and Introduction
9:30 am: Carlo Croce ”The role of microRNAs in human Cancer”
10.20am: Sandra Cascio “Alternative Splicing of Human MUC1 Oncogene: Functional
Significance of MUC1 Isoforms”
10.50 am: Cecilia Lo “Mutagenesis discovery of the cilium as a central pathway to congenital heart disease”
11.40 am: Coffee Break
12.00 am: Chiara Milanese “Zebrafish as a Model to Study Neurodegeneration”
12.30 am: Pierangelo Cifelli “Experimental Temporal Lobe Epilepsy in the Rat is Associated with Increased Dopamine Neuron Activity: A Model of Psychosis”
1.00 pm: Lunch
2.00 pm: Rocky Tuan “Adult Stem Cells and Nanomaterials in Skeletal Tissue Engineering and Regeneration”
2.50 pm: Roberto Di Maio “Pilocarpine alters NMDA receptor subunit expression and function in hippocampal cells: NADPH oxidase and ERK mechanisms.”
3.20 pm: Rino Rappuoli “Vaccines: Health Insurance for the 21st Century”
4.10 pm: Chiara Cipollina “New Mediators in Inflammation: Cyclooxygenase-2 Dependent Omega-3 Fatty Acid Derivatives”
4.40 pm: Valentina Di Caro “Molecular Mechanisms of Action of Autoimmune Diabetes-Suppressive Dendritic Cells”
5.10 pm: Arthur Levine, Closure of the meeting
